An open-label, prospective, and post-authorization observational study. This non-interventional study is designed to establish the importance of the measurement of HRQoL data and patient-reported outcomes in clinical practice in patients with RA, and to assess efficacy and safety use of CZP according to the summary of product characteristics.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01526434?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
